Market Research Industry Today

Messenger RNA Market is Set to Grow Substantially in Next 10 Years - BIS Research

The global messenger RNA market is growing rapidly, led by North America, with Asia-Pacific emerging as the fastest-growing region. Key innovations include virtual clinical trials, advanced lipid delivery systems, and self-amplifying mRNA. Trends such as AI-driven design and personalized vaccines are accelerating the development of next-generation therapies.
Published 16 June 2025

What is Messenger RNA? 

Messenger RNA (mRNA) is a single-stranded molecule that carries genetic instructions from DNA to the cell’s protein-making machinery. It serves as the blueprint for building proteins by directing ribosomes on how to assemble amino acids in the correct sequence. Created during transcription, mRNA plays a crucial role in translating genetic information into functional proteins. It is short-lived and degrades after use, allowing cells to regulate protein production efficiently. mRNA is also the foundation of several medical breakthroughs, including mRNA-based vaccines like those for COVID-19, and is increasingly used in cancer therapies and personalized medicine. 

What is the Current Market Outlook for Messenger RNA? 

The global messenger RNA therapeutics market is increasingly in significant demand and is expected to grow substantially in upcoming years. North America currently leads the market, while Asia-Pacific is the fastest-growing region due to rising investments and expanding biotech infrastructure. 

What is the key Innovation & Trends in Messenger RNA Market? 

The market is being shaped by major innovations such as virtual clinical trials, advanced lipid nanoparticle delivery systems, and self-amplifying mRNA platforms. Key trends include the rise of personalized cancer vaccines and the use of AI for optimizing mRNA sequences and delivery design, accelerating the development of targeted, effective therapies. 

How Does This Report Help Organizations Drive Strategic Growth? 


  • Understand the mRNA therapeutics landscape from molecular design to clinical application. 
  • Identify high-growth regions and expanding use cases in vaccines, oncology, and rare diseases. 
  • Track key innovations like self-amplifying mRNA, lipid nanoparticle delivery, and AI-optimized sequencing. 
  • Benchmark leading players and emerging platforms transforming personalized medicine. 
  • Support investment strategy, R&D prioritization, and global market entry planning. 


Explore the Full TOC and Download Report Sample >>  


What Are the Key Demand Drivers and Challenges in the Messenger RNA Market? 


Drivers: 

• Advancements in mRNA Technology  

• Rising Demand for mRNA Vaccines  

• Growing Applications in Cancer Therapy 

Challenges: 

• High Cost of mRNA Production 


What is the Market Segmentation in Messenger RNA Market? 

Based on Application 

• Oncology 

• Infectious Diseases  

• Rare Genetic Diseases 

• Respiratory Diseases 

• Other Applications 

Based on Region 

• North America 

• Europe 

• Asia-Pacific 

• Latin America 

• Rest-of-the-World   

What Is the Competitive Landscape in Messenger RNA Market?

 

Strategic Initiatives 

Leading pharmaceutical and biotech companies are actively investing in the expansion of mRNA applications beyond vaccines into oncology, rare genetic diseases, and respiratory conditions. Strategic partnerships such as Etherna Immunotherapies’ collaboration with Dropshot Therapeutics and Achilles Therapeutics' alliance with Arcturus are accelerating next-generation mRNA therapeutics development. Regulatory agencies are also playing a key role; the U.S. FDA’s fast-track designation for Arcturus' sa-mRNA vaccine candidate (ARCT-2304) highlights institutional support for rapid innovation in this space. 


Here Are Some Case Studies and Success Stories in Messenger RNA Market 

Arcturus Therapeutics is a prime example of mRNA innovation in action. In 2025, it secured fast-track status from the FDA for ARCT-2304, a self-amplifying mRNA vaccine candidate. Simultaneously, Arcturus partnered with Achilles Therapeutics to co-develop personalized mRNA cancer vaccines. These initiatives showcase how cross-sector collaboration and regulatory alignment can fast-track mRNA-based solutions across infectious and oncological indications. 


[Schedule a Call with Industry Experts] 


[Download Complete TOC] 


Related Reports from BIS Research 

  mRNA Vaccines and Therapeutics Market  

Neoantigen Cancer Vaccine      

Hematology Testing Market      


About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   


Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   


Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch 


 



 


 


Other Industry News

Ready to start publishing

Sign Up today!